Weight-loss drugs are popular but not covered by insurance, creating an expensive cycle. Arm's IPO and its role in chip design are discussed. Other topics include extreme weather's impact, interest rate hikes, combating AI misinformation, and animated NFL games. The podcast explores the popularity of weight-loss drugs, their impact on patients, and the influence of celebrities and social media.
11:54
AI Summary
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
Weight-loss drugs like Osempic and wego V are increasingly popular, but insurance companies are unlikely to cover them, leading to limited access for those who truly need them.
The popularity of weight-loss drugs among the rich and famous has caused shortages and high prices, leaving ordinary individuals with the tough decision of whether to pay for them themselves and potentially go into debt.
Deep dives
Arm's IPO and Business Model
Arm, a chip maker that designs chips and sells the designs to chip makers, debuted on the NASDAQ with a $54.5 billion valuation. Their business model is based on royalty, and a significant portion of their revenue comes from past products. Arm has strategic partnerships with NVIDIA and TSMC, and while their early momentum is promising, it is uncertain if it will sustain in the long term.
Extreme Weather's Impact on the Fashion Industry
A study shows that extreme weather could cost the global fashion industry $65 billion in missed earnings by 2030. Countries such as Bangladesh, Pakistan, Vietnam, and Cambodia are at risk of losing export earnings and jobs due to weather-related issues. In other news, the European Central Bank raised interest rates for the 10th consecutive time, and Craig Newmark, the founder of Craigslist, pledged $3 million to fund an AI literacy program and AI ratings to combat AI misinformation.
Challenges with Weight Loss Drugs
Popular weight loss drugs like Osempic and wego V, initially designed for type 2 diabetes, are now being used by people for weight loss. However, the drugs' popularity among the rich and famous has caused increased demand, shortages for those who truly need them, and high prices. Insurance companies often view these drugs as lifestyle enhancements rather than medical necessities, leading to limited coverage. This leaves ordinary individuals with the tough decision of whether to pay for the drugs themselves and potentially go into debt.
Weight-loss drugs are increasingly popular, but insurance companies are still unlikely to cover them. It’s turning into a vicious, expensive cycle. Plus: the Arm IPO and the NFL gets a “Toy Story” makeover.
Join our hosts Mark Dent and Rob Litterst as they take you through our most interesting stories of the day.
Thank You For Listening to The Hustle Daily Show. Don’t forget to hit Subscribe or Follow us on Apple Podcasts so you never miss an episode! If you want this news delivered to your inbox, join millions of others and sign up for The Hustle Daily newsletter, here: https://thehustle.co/email/